Archives des Oncologie - Page 2 sur 5

06/09/2022

Cancers (Basel)

Oncologie

Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study

11/08/2022

Frontiers in oncology

Oncologie

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies

06/08/2022

JCO precision oncology

Oncologie

Immunoscore Is Prognostic in Low-Risk and High-Risk Stage III Colon Carcinomas Treated With Adjuvant Infusional Fluorouracil, Leucovorin, and Oxaliplatin in a Phase III Trial

16/07/2022

Cancer letters

Oncologie

Predictive biomarkers for personalized medicine in breast cancer

27/04/2022

Frontiers in Immunology

Oncologie

Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition

08/02/2022

Frontiers in Immunology

Oncologie

The Effect of Hypoxia and Hypoxia-Associated Pathways in the Regulation of Antitumor Response: Friends or Foes?

04/02/2022

Oncoimmunology

Oncologie

Immune sunrise: from the immunome to the cancer immune landscape

07/09/2021

Cancer Research

Oncologie

Allosteric inhibition of HER2 by Moesin-mimicking compounds targets HER2-positive cancers and brain metastases

01/07/2021

Cancers (Basel)

Oncologie

Mitochondrial Metabolism in Carcinogenesis and Cancer Therapy

11/05/2021

Blood.

Oncologie

GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness

01/05/2021

Cells

Oncologie

Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer

25/04/2021

Oncoimmunology

Oncologie

Tumor spread or siege immunity: dissemination to distant metastasis or not